Skip to content

Ocular Therapeutix OCUL Market capitalization

Market capitalization at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Bausch + Lomb logo
Bausch + LombBLCO
$5.63B+10.2%
HRO
HarrowHROW
$1.31B+38.4%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.99B+41.1%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$2.33B+1,477%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$2.06B-39.4%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Computed from the period-end share price: $1.84B.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's market capitalization?
Ocular Therapeutix (OCUL) reported market capitalization of $1.84B in Q1 2026.
How has Ocular Therapeutix's market capitalization changed year-over-year?
Ocular Therapeutix's market capitalization increased by 58.2% year-over-year, from $1.17B to $1.84B.
What is the long-term trend for Ocular Therapeutix's market capitalization?
Over 5 years (2020 to 2025), Ocular Therapeutix's market capitalization has grown at a 10.3% compound annual growth rate (CAGR), from $1.59B to $2.59B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.